The frequency of psychological conditions in recovered COVID-19 patients with AcuteKidney Injury (AKI) and their informal primary caregivers (IPC) is unknown; as well asthe effects of psychological therapy in this population. The present study was initiatedto determine the effectiveness of a brief remote psychological intervention (BRPI) toreduce anxious and depressive symptoms in survivors of AKI.The investigator designed a single-case experimental design A-B with prospectivefollow-up. We used the Patient Health Questionnaire-9 (PHQ-9) and the General AnxietyDisorder Scale-7 (GAD-7) to screen for depressive and anxiety symptoms, one week laterafter hospital discharge. Those with moderate or severe symptoms received cognitivebehavioral therapy (CBT) and were evaluated over time with the instruments and dailyself-report of symptoms. The statistical analysis was conducted using statisticalsoftware.
Not Provided
Behavioral: Cognitive behavioral therapy
The investigator adapted the manual of psychological intervention based on Cognitive
Behavioral Therapy (CBT) which previously was validated in patients with chronic kidney
disease. Patients received CBT using a model of six modules, with a time of 60 minutes
for each weekly session. For each module, a skill acquisition criterion was used, to know
if the participants were putting the techniques into practice in their daily lives and to
know if it was pertinent to move on to the next module. Modules were adapted to the needs
of each participant. In consequence, the number of sessions was different for each
patient. All participants had a follow-up session one month after they finished the
psychological therapy. Additionally, a daily self-record of symptoms perception and a
short questionnaire on the usefulness of each technique used were sent daily to the
participants via a phone text message.
Inclusion Criteria:
- Survivors of severe COVID-19 who had AKI during hospitalization
- Informal primary caregivers
Exclusion Criteria:
- They did not accept to participate in the study
- They did not answer three attempted phone calls or text messages making it
impossible to complete the intervention.
National Institute of Respiratory Diseases
Mexico City 3530597, Mexico City 3527646, Mexico
Jesús Rivero, MD, Principal Investigator
INER